Cartesian Therapeutics, Inc. (RNAC)

$8.04 +8.42%

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-08-07 ESTIMATED

Cartesian Therapeutics, Inc. (RNAC) has reported earnings 18 times since May 13, 2021. The stock moves an average of ±6.13% the day after reporting, closing higher 50.0% of the time. Its largest post-earnings gain was +31.68% (Mar 09, 2026) and its largest decline was -9.43% (Aug 08, 2024). The next earnings report is predicted for 2026-08-07 (estimated).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.13%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date	Timing	Open	High	Close	Volume	Movement %	SEC Filing
Apr 30, 2026	☀ PRE	$6.41	$6.55	$6.22	136,444	-3.86%	open_in_new
Mar 09, 2026	☀ PRE	$6.55	$9.16	$9.02	2,932,300	+31.68%	open_in_new
Nov 06, 2025	☀ PRE	$5.98	$8.15	$7.55	309,400	-1.56%	open_in_new
Aug 07, 2025	☀ PRE	$11.45	$11.82	$10.54	48,100	-6.56%	open_in_new
May 08, 2025	☀ PRE	$10.26	$11.31	$10.42	69,500	+2.66%	open_in_new
Mar 13, 2025	☀ PRE	$17.13	$17.42	$16.61	102,900	-4.98%	open_in_new
Nov 07, 2024	☀ PRE	$21.11	$22.20	$20.78	92,300	-0.38%	open_in_new
Aug 08, 2024	☀ PRE	$15.00	$15.00	$12.87	156,800	-9.43%	open_in_new
May 08, 2024	☀ PRE	$23.00	$23.51	$23.25	41,200	+0.19%	open_in_new
Mar 07, 2024	☀ PRE	$21.09	$21.09	$19.32	20,387	-8%	open_in_new
Aug 17, 2023	☀ PRE	$32.10	$34.20	$33.60	46,373	+2.75%	open_in_new
Nov 03, 2022	☀ PRE	$47.70	$51.30	$50.70	37,263	+3.68%	open_in_new
Aug 04, 2022	☀ PRE	$52.80	$59.70	$56.40	124,720	+13.94%	open_in_new
May 05, 2022	☀ PRE	$26.10	$26.40	$24.30	45,110	+1.12%	open_in_new
Mar 10, 2022	☀ PRE	$58.56	$60.60	$52.50	38,077	+0%	open_in_new
Nov 09, 2021	☀ PRE	$116.40	$117.00	$115.50	55,667	-2.78%	open_in_new
Aug 12, 2021	☀ PRE	$118.80	$134.40	$131.10	75,610	+14.4%	open_in_new
May 13, 2021	☀ PRE	$90.00	$92.70	$87.90	40,840	-2.33%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.13%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
144	20260609	open_in_new SEC.gov
8-K	20260609	open_in_new SEC.gov
144	20260602	open_in_new SEC.gov
8-K	20260526	open_in_new SEC.gov
SCHEDULE 13G/A	20260506	open_in_new SEC.gov
10-Q	20260430	open_in_new SEC.gov
8-K	20260430	open_in_new SEC.gov
S-8	20260430	open_in_new SEC.gov
DEF 14A	20260428	open_in_new SEC.gov
DEFA14A	20260428	open_in_new SEC.gov

Frequently asked about RNAC earnings

When does Cartesian Therapeutics, Inc. report earnings next? expand_more

Cartesian Therapeutics, Inc. (RNAC)'s next earnings date is estimated for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does RNAC stock move after earnings? expand_more

Over 18 reports, RNAC has moved an average of ±6.13% the session after earnings, closing higher 50.0% of the time.

What was RNAC's biggest post-earnings move? expand_more

RNAC's largest post-earnings gain on record was +31.68% on Mar 09, 2026, and its largest decline was -9.43% on Aug 08, 2024.

Where can I find Cartesian Therapeutics, Inc.'s SEC filings? expand_more

All of Cartesian Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.